Nuwellis (NUWE) Research & Development (2011 - 2026)
Nuwellis' (NUWE) quarterly Research & Development came in at $942000.0 in Q2 2026, up 39.56% on a YoY basis from $675000.0 in Q2 2025, and down 45.49% quarter-over-quarter from $1.7 million in Q1 2026.
Analysis
Nuwellis (NUWE) Research & Development (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Research & Development for 16 consecutive years, with $942000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 39.56% year-over-year to $942000.0; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 63.53% YoY), and the FY2025 full-year result was $2.7 million, down 15.49% from the prior year.
- Research & Development declined to $942000.0 in Q2 2026 per NUWE's latest filing, from $1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $1.7 million in Q1 2026 and bottomed at $486000.0 in Q3 2024.
- Historically, Research & Development has averaged $1.0 million across 5 years, with a median of $1.0 million in 2022.
- The sharpest annual moves came in 2024 and 2026: Research & Development sank 62.92% in 2024, then jumped 214.18% in 2026.
- Over 5 years, Research & Development stood at $1.2 million in 2022, then gained by 14.24% to $1.4 million in 2023, then tumbled by 39.43% to $831000.0 in 2024, then gained by 6.38% to $884000.0 in 2025, then gained by 6.56% to $942000.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $942000.0, $1.7 million, and $884000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 942,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 942,000.00 |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 884,000.00 |
| Sep 30, 2025 | 603,000.00 |
| Jun 30, 2025 | 675,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 486,000.00 |
| Jun 30, 2024 | 558,000.00 |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 928,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 1.73 Mn |